Ambryon Biosciences

Enhanced proofreading governs CRISPR–Cas9 targeting accuracy

Chen et al. (2017). NatureResearch

High-fidelity SpCas9 variants cut off-targets less, but how they discriminated was unknown; smFRET showed the non-catalytic REC3 domain senses complementarity and gates HNH activation. That model yielded the hyper-accurate HypaCas9.

Key findings

  • SpCas9-HF1 and eSpCas9(1.1) cleave on-target DNA at wild-type-like rates and mismatched substrates significantly more slowly, yet their dissociation constants for on-target and PAM-distal mismatched substrates match wild-type SpCas9, so specificity does not come from reduced binding affinity.

  • HypaCas9 is SpCas9 with REC3 alanine substitutions N692A, M694A, Q695A and H698A, and retains more than 70% of wild-type on-target activity at 19 of 24 human sites, versus 18 of 24 for SpCas9-HF1 and 23 of 24 for eSpCas9(1.1).

  • By GUIDE-seq across six sgRNAs, HypaCas9 detects dramatically fewer genome-wide off-target sites than wild-type SpCas9 and matches or improves on SpCas9-HF1 and eSpCas9(1.1) for every sgRNA, at comparable on-target editing and tag integration efficiency among all four nucleases.

Described parts & designs

Other parts & designs used

Author abstract

The RNA-guided CRISPR-Cas9 nuclease from Streptococcus pyogenes (SpCas9) has been widely repurposed for genome editing. High-fidelity (SpCas9-HF1) and enhanced specificity (eSpCas9(1.1)) variants exhibit substantially reduced off-target cleavage in human cells, but the mechanism of target discrimination and the potential to further improve fidelity were unknown. Using single-molecule Förster resonance energy transfer (smFRET) experiments, we show that both SpCas9-HF1 and eSpCas9(1.1) are trapped in an inactive state when bound to mismatched targets. We find that a non-catalytic domain within Cas9, REC3, recognizes target complementarity and governs the HNH nuclease to regulate overall catalytic competence. Exploiting this observation, we designed a new hyper-accurate Cas9 variant (HypaCas9) that demonstrates high genome-wide specificity without compromising on-target activity in human cells. These results offer a more comprehensive model to rationalize and modify the balance between target recognition and nuclease activation for precision genome editing.

Identifiers & revision